Metastatic Colorectal Cancers Completed Phase 2 Trials for Necitumumab (DB09559)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00835185Study of IMC-11F8 in Participants With Colorectal CancerTreatment